Finance

Lists
NXG:CVE
NexgenRx Inc
0,71 CAD
+1,43%
(+0,0100) 1D
17-ноя., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NXG...
Open
0,71 CAD
High
0,71 CAD
Low
0,71 CAD
Mkt. cap
50,49 млн
Avg. vol.
16,59 миң
Volume
962,00
Dividend
2,11%
Quarterly dividend
0,00 CAD
Ex-dividend date
2026-ж., 2-ноя.
P/E ratio
23,89
52-wk high
0,75 CAD
52-wk low
0,29 CAD
EPS
0,03 CAD
Beta
0,76
Shares outstanding
71,12 млн
No. of employees
20
Open
0,71 CAD
High
0,71 CAD
Low
0,71 CAD
Mkt. cap
50,49 млн
Avg. vol.
16,59 миң
Volume
962,00
Dividend
2,11%
Quarterly dividend
0,00 CAD
Ex-dividend date
2026-ж., 2-ноя.
P/E ratio
23,89
52-wk high
0,75 CAD
52-wk low
0,29 CAD
EPS
0,03 CAD
Beta
0,76
Shares outstanding
71,12 млн
No. of employees
20
News stories
From web sources and news partners
About NexgenRx Inc
CEO-
Employees20
Founded2003
HeadquartersТоронто, Онтарио, Канада
SectorFinancials
IndustryInsurance
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,62 млн
4,42 млн
5,00 млн
5,16 млн
Cost of goods sold
765,82 миң
520,55 миң
744,85 миң
743,24 миң
Cost of revenue
765,82 миң
520,55 миң
744,85 миң
743,24 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 млн
2,89 млн
2,77 млн
3,17 млн
Operating expense
3,24 млн
3,16 млн
3,00 млн
3,39 млн
Total operating expenses
4,01 млн
3,68 млн
3,75 млн
4,14 млн
Operating income
609,09 миң
734,96 миң
1,25 млн
1,02 млн
Other non operating income
-35,66 миң
-37,72 миң
-37,74 миң
-39,73 миң
EBT including unusual items
566,92 миң
533,63 миң
1,21 млн
970,24 миң
EBT excluding unusual items
566,92 миң
692,69 миң
1,21 млн
979,84 миң
Income tax expense
-22,86 миң
714,41 миң
-22,86 миң
-22,86 миң
Effective tax rate
-4,03%
133,88%
-1,90%
-2,36%
Other operating expenses
-
-
-
-
Net income
589,78 миң
-180,78 миң
1,23 млн
993,10 миң
Net profit margin
12,78%
-4,09%
24,58%
19,24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6,50 миң
-4,55 миң
-5,61 миң
-5,00 миң
Net interest expenses
-6,50 миң
-4,55 миң
-5,61 миң
-5,00 миң
Depreciation and amortization charges
61,14 миң
46,72 миң
56,45 миң
58,65 миң
EBITDA
922,43 миң
790,08 миң
1,30 млн
1,25 млн
Gain or loss from assets sale
-
-2,33 миң
-
9,60 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору